pGEX-4T1-14-3-3 epsilon GST Citations (5)

Originally described in: The structural basis for 14-3-3:phosphopeptide binding specificity.
Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC Cell. 1997 Dec 26. 91(7):961-71. PubMed Journal

---

Articles Citing pGEX-4T1-14-3-3 epsilon GST

Articles
AS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane. Koumanov F, Richardson JD, Murrow BA, Holman GD. J Biol Chem. 2011 May 13;286(19):16574-82. doi: 10.1074/jbc.M111.226092. Epub 2011 Mar 17. PubMed
Phosphorylation of threonine residues on Shc promotes ligand binding and mediates crosstalk between MAPK and Akt pathways in breast cancer cells. Suen KM, Lin CC, Seiler C, George R, Poncet-Montange G, Biter AB, Ahmed Z, Arold ST, Ladbury JE. Int J Biochem Cell Biol. 2018 Jan;94:89-97. doi: 10.1016/j.biocel.2017.11.014. Epub 2017 Dec 5. PubMed
The kinase activity of the channel-kinase protein TRPM7 regulates stability and localization of the TRPM7 channel in polarized epithelial cells. Cai N, Lou L, Al-Saadi N, Tetteh S, Runnels LW. J Biol Chem. 2018 Jul 20;293(29):11491-11504. doi: 10.1074/jbc.RA118.001925. Epub 2018 Jun 4. PubMed
FYN and ABL regulate the interaction networks of the DCBLD receptor family. Schmoker AM, Weinert JL, Markwood JM, Albretsen KS, Lunde ML, Weir ME, Ebert AM, Hinkle KL, Ballif BA. Mol Cell Proteomics. 2020 Jun 30. pii: RA120.002163. doi: 10.1074/mcp.RA120.002163. PubMed
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling. Tripathi R, Liu Z, Jain A, Lyon A, Meeks C, Richards D, Liu J, He D, Wang C, Nespi M, Rymar A, Wang P, Wilson M, Plattner R. Nat Commun. 2020 Oct 29;11(1):5463. doi: 10.1038/s41467-020-19075-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.